Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)

Clinical Trial Title

Alzheimer's Disease Neuroimaging Initiative 3

National Clinical Trial Number:

NCT02854033

Contact Information

Clinical Trial Protocol Description:

This study (ADNI3) looks at the relationship between clinical, cognitive (thinking and memory), imaging scans, genetic (hereditary) and biomarker (substance used as an indicator) tests over time. This will help researchers to better understand Alzheimer's disease from its earliest stages.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Be 55-90 years old
  • Have an individual who knows you well, willing to take part in the study with you as your study partner.

You will be excluded from the study if any of the following criteria apply to you:

  • Are unable or unwilling to complete all study activities

This is a partial list of inclusion and exclusion criteria.

Study Details

Clinical Trial Investigator

Raj C. Shah, MD

Contact Information

Judy Phillips

Clinical Trial Location

Rush University Medical Center

Location

Rush University Medical Center

1620 W Harrison St
Chicago, IL 60612

Get Directions

Clinical Trial FAQs

Find out if a clinical trial makes sense for you.

Learn more
Learn more